Anti-Human CD80/B7-1 Monoclonal Antibody (1A689) from ProteoGenix; catalogue ARO-A23447; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human CD80/B7-1 Monoclonal Antibody (1A689) is a highly specific and potent antibody designed for use in immunological research. This cutting-edge biotech product has been rigorously tested and validated to ensure its effectiveness in a variety of experimental settings.
The Anti-Human CD80/B7-1 Monoclonal Antibody (1A689) targets the CD80/B7-1 protein, which is a critical co-stimulatory molecule involved in T cell activation and immune response regulation. By binding to CD80/B7-1, this antibody blocks its interaction with its receptor, CD28, thus inhibiting T cell activation. This makes it an invaluable tool for studying immune responses and the role of CD80/B7-1 in various diseases.
The Anti-Human CD80/B7-1 Monoclonal Antibody (1A689) has a wide range of applications in immunological research. It is commonly used in flow cytometry, immunohistochemistry, and western blotting techniques to detect and quantify the expression of CD80/B7-1 in various cell types and tissues. Additionally, this antibody can be used in functional assays to investigate the role of CD80/B7-1 in immune cell interactions and signaling pathways.
The Anti-Human CD80/B7-1 Monoclonal Antibody (1A689) has been successfully used in numerous experimental studies. For example, it has been used to study the role of CD80/B7-1 in autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. It has also been used to investigate the impact of CD80/B7-1 on immune checkpoint blockade therapies for cancer treatment. Furthermore, this antibody has been used in studies on infectious diseases, transplantation, and immunodeficiency disorders.
Incorporating , this powerful antibody is a valuable tool for researchers studying CD80/B7-1 and its role in various diseases and immune responses. Its specificity and potency make it an ideal choice for a wide range of experimental techniques, providing reliable and reproducible results. With its proven effectiveness and versatility, the Anti-Human CD80/B7-1 Monoclonal Antibody (1A689) is a must-have for any immunological research laboratory. Order now and take your research to the next level!
ProteoGenix catalogue number ARO-A23447. For research use only.
Target: T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7, CD80, CD80; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
